ANDA 60520, held by Pharmacia And Upjohn. Neomycin Sulfate.
As of Nov 15, 2026, ANDA 60520 (Mycifradin), held by Pharmacia And Upjohn, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| MycifradinEQ 350MG BASE ยท tablet;oral | Neomycin Sulfate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
